Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 31 2020

Full Issue

FDA Chief: Doctors Can Make Own Decisions About Hydroxychloroquine

While Stephen Hahn says the FDA is not in a position to "regulate the practice of medicine," a group of researchers oppose doctors prescribing the anti-malarial drug for COVID.

The Hill: FDA Chief: Hydroxychloroquine Use A Decision Between Doctor And Patient 

Stephen Hahn, the commissioner of the Food and Drug Administration (FDA), on Thursday declined to take a definitive stance on whether people should take hydroxychloroquine as a treatment for the coronavirus, instead saying that decision should be made between a doctor and a patient. “We had data that when this drug was combined with others, there was some risk associated with that. But the question you’re asking me is a decision between a doctor and a patient,” Hahn said on NBC’s “Today” show. (Axelrod, 7/30)

CNN: Hydroxychloroquine: Researchers Publish Scathing Critique Of Henry Ford Study Touted By The White House 

Researchers on Wednesday published scathing critiques of a study President Trump repeatedly touted on Twitter. That study, published earlier this month in the International Journal of Infectious Diseases, claimed to show that hydroxychloroquine saved lives. President Trump tweeted about it enthusiastically. (Cohen, 7/31)

Kaiser Health News and Politifact HealthCheck: Don’t Fall For This Video: Hydroxychloroquine Is Not A COVID-19 Cure 

Millions of people, including the president of the United States, have seen or shared a video in which a doctor falsely claims there is a cure for the coronavirus, and it’s a medley starring hydroxychloroquine. The video shows several doctors in white coats giving a press conference outside the Supreme Court in Washington, D.C. It persists on social media despite bans from Facebook, Twitter and YouTube, and it was published by Breitbart, a conservative news site. (Funke, 7/31)

Also —

The Hill: Ohio Pharmacy Board Backtracks, Withdraws Rule Barring Use Of Hydroxychloroquine To Treat Coronavirus

The State of Ohio Board of Pharmacy on Thursday withdrew a rule that would have barred pharmacists, licensed distributors of drugs and medical institutions from prescribing the controversial anti-malaria drug hydroxychloroquine to treat or prevent the novel coronavirus after Gov. Mike DeWine (R) voiced concerns. The state pharmacy board said in a memo on Wednesday that the rule would, in general, prohibit the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19... But the rule quickly met with pushback from DeWine (R), who urged the state board to reconsider the decision the day it went into effect. (Wise, 7/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
  • Thursday, May 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF